Lundbeck får godkendt skizofrenimiddel i Canada

Lundbeck og selskabets japanske partner, Otsuka Pharmaceutical Co., har fået grønt lys til at markedsføre skizofrenimidlet Rexulti i Canada. Det fremgår af en fælles meddelelse fra sels …

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: